Angiotensin converting enzyme inhibitors in treatment practice: similarity and difference. How to make the right choice

Angiotensin converting enzyme inhibitors in treatment practice: similarity and difference. How to make the right choice

The article focuses on differential choice of ACE inhibitor in clinical practice. Mechanisms of action common for all drugs in this group, indications and benefits are described. Differences in pharmacokinetic features, RAAS blockade, additional unique attributes, indications and strength of evidenc...

Full description

Bibliographic Details
Main Authors:	O. D. Ostroumova, G. N. Schukina, V. M. Fomina
Format:	Article
Language:	Russian
Published:	Remedium Group LLC 2013-12-01
Series:	Медицинский совет
Subjects:	hypertension atherosclerosis coronary heart disease stroke ace inhibitors ramipril
Online Access:	https://www.med-sovet.pro/jour/article/view/1102

Similar Items

Ramipril - angiotensin converting enzyme ingibitor with a wide spectrum of therapeutic action
by: Dmitriy Vladimirovich Preobrazhenskiy,, et al.
Published: (2009-03-01)

CARDIOPROTECTIVE AND NEPHROPROTECTIVE EFFECTS OF ANGIOTENSIN CONVERTING ENZYME INHIBITOR RAMIPRIL
by: D. A. Napalkov, et al.
Published: (2016-01-01)

ACE INHIBITOR POSSIBILITIES IN CLINICAL PRACTICE: WHAT WE KNOW ABOUT THEM?
by: D. V. Nebieridze, et al.
Published: (2016-01-01)

THE CAPABILITIES OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN CLINICAL PRACTICE: FOCUS ON VASOPROTECTION
by: D. B. Nebieridze, et al.
Published: (2015-12-01)

Dose response of ACE inhibitors: implications of the SECURE trial
by: Lonn Eva
Published: (2001-07-01)

FIXED COMBINATION OF THE CALCIUM CHANNEL BLOCKER LERCANIDIPINE AND ANGIOTENSIN CONVERTING ENZYME INHIBITOR ENALAPRIL: POSSIBILITY OF USAGE
by: O. D. Ostroumova, et al.
Published: (2015-09-01)

Renin‐angiotensin aldosterone profile before and after angiotensin‐converting enzyme‐inhibitor administration in dogs with angiotensin‐converting enzyme gene polymorphism
by: Darcy Adin, et al.
Published: (2020-03-01)

Antihypertensive effects of Ocimum gratissimum extract: Angiotensin-converting enzyme inhibitor in vitro and in vivo investigation
by: Huey-Mei Shaw, et al.
Published: (2017-08-01)

Synthesis of angiotensin-converting enzyme (ACE) inhibitors: an important class of antihypertensive drugs
by: Lima Dênis Pires de
Published: (1999-01-01)

Influence of angiotensin-converting enzyme inhibitor ramipril on indicators of tubular kidney lesion in patients with chronic glomerulonephritis
by: Dolinna Mariia O., et al.
Published: (2020-03-01)

Efficiency (advantages) of ramipril in arterial hypertension and diabetes mellitus from the point of view of evidence-based medicine
by: M. V. Leonova
Published: (2020-05-01)

SARTANS AND ANGIOTENSIN CONVERTING ENZYME INHIBITORS: A DUEL BETWEEN TWO LEADERS OF PHARMACOTHERAPY OF CARDIOVASCULAR DISEASES
by: K. A. Gyamdzhyan, et al.
Published: (2015-12-01)

ESTIMATION OF NEPHROPROTECTIVE EFFECT OF ANGIOTENSIN-CONVERTING ENZYME RAMIPRIL IN PATIENTS WITH CHRONIC GLOMERULONEPHRITIS
by: M.A. Dolinnayä, et al.
Published: (2017-03-01)

ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN MANAGEMENT OF PATIENTS WITH CHRONIC HEART FAILURE
by: S. N. Tereshchenko, et al.
Published: (2016-01-01)

The Potential of Hydrolysate from Rabbit Meat Protein as an Angiotensin Converting Enzyme Inhibitor
by: Edy Permadi, et al.
Published: (2019-02-01)

Prevention of cardiovascular events at patients with arterial hypertension at treatmentangiotensin-converting enzyme inhibitor.
by: Oksana Andreevna Kislyak, et al.
Published: (2009-09-01)

Ramipril Reduces Acylcarnitines and Distinctly Increases Angiotensin-Converting Enzyme 2 Expression in Lungs of Rats
by: Berger, C., et al.
Published: (2022)

Effect of Ramipril on Renin-Angiotensin-Aldosterone System of Young and Middle-Aged Patients with Hypertension
by: Hui-Ling Yuan
Published: (2020-12-01)

CORRELATION BETWEEN ANGIOTENSIN-CONVERTING ENZYME INHIBITORS LIPOPHILICITY AND PROTEIN BINDING DATA
by: Jasna Trbojević-Stanković, et al.
Published: (2012-01-01)

Uremic Apelin and Leucocytic Angiotensin-Converting Enzyme 2 in CKD Patients
by: Bogusz Trojanowicz, et al.
Published: (2020-11-01)

Comparing recommended doses of angiotensin receptor blockers and ACE inhibitors (CORD Study)
by: J. Spinar, et al.
Published: (2009-08-01)

Theoretical Assessment of Therapeutic Effects of Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors on COVID-19
by: Azadeh Khalili, et al.
Published: (2021-07-01)

Effectiveness of ACE inhibitor ramipril and its combination with hydrochlorothiazide in patients with arterial hypertension and overweight: CHARISMA Study
by: I. P. Kolos, et al.
Published: (2008-04-01)

Whether all ACE inhibitors enzyme are identical? Focus on zofenopril.
by: Lyudmila Gennadievna Ratova, et al.
Published: (2009-09-01)

Investigation of the Mechanism and Effect of Enalapril, Angiotensin-Converting Enzyme (ACE) Inhibitor, on Proliferation, Apoptosis, and Migration in Colorectal Cancer Cells
by: Asma Mostafapour, et al.
Published: (2020-08-01)

Optimization of drug therapy of coronary heart disease and arterial hypertension: choice angiotensin-converting enzyme inhibitors
by: D I Trukhan, et al.
Published: (2014-03-01)

ACE inhibitors in arterial hypertension treatment among various clinical groups
by: O. D. Ostroumova, et al.
Published: (1970-01-01)

State of renal hemodynamics and nephrofibrosis parameters in patients with nephrolithiasis applying angiotensin converting enzyme inhibitors
by: P.V. Glybochko, et al.
Published: (2010-03-01)

TREATMENT OF HYPERTENSIVE PATIENTS WITH HIGH OR VERY HIGH CARDIOVASCULAR RISK. PHARMACOECONOMIC EFFICIENCY OF A TRIPLE COMBINATION THERAPY CONTAINING ANGIOTENSIN CONVERTING ENZYME INHIBITOR, CALCIUM CHANNEL BLOCKER AND STATIN
by: I. N. DYAKOV
Published: (2016-12-01)

Controversy of angiotensin receptor blockers (ARBs) and angiotensin converting enzymeinhibitors (ACEIs) prescription for hypertension patients in coronavirus disease 2019 (COVID-19) pandemic
by: Yuliana Yuliana
Published: (2020-05-01)

Update on the Angiotensin Converting Enzyme 2-Angiotensin (1-7)-Mas Receptor Axis: Fetal Programming, Sex Differences and Intracellular Pathways
by: Mark C. Chappell, et al.
Published: (2014-01-01)

Normal-phase thin-layer chromatography of some angiotensin converting enzyme (ACE) inhibitors and their metabolites
by: Odović Jadranka, et al.
Published: (2009-01-01)

Normal-phase thin-layer chromatography of some angiotensin converting enzyme (ACE) inhibitors and their metabolites
by: JADRANKA ODOVIĆ, et al.
Published: (2009-06-01)

Impact of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on the Inflammatory Response and Viral Clearance in COVID-19 Patients
by: Linna Huang, et al.
Published: (2021-08-01)

Tryptophanhaltige Dipeptide als Hemmstoffe für das Angiotensin-Converting Enzyme
by: Hagemann, Diana
Published: (2017)

A Review of the Role of Bradykinin and Nitric Oxide in the Cardioprotective Action of Angiotensin-Converting Enzyme Inhibitors: Focus on Perindopril
by: Arnaud Ancion, et al.
Published: (2019-10-01)

Moringa oleifera leaves methanolic extract inhibits angiotensin converting enzyme activity in vitro which ameliorates hypertension
by: Suraiya Aktar, et al.
Published: (2019-08-01)

ELIMINATION OF ANGIOTENSIN – CONVERTING ENZIME INHIBITORS BY PERITONEAL DIALISATE
by: Jadranka Odović, et al.
Published: (2011-06-01)

Reversed-phase thin-layer chromatography of some angiotensin converting enzyme (ACE) inhibitors and their active metabolites
by: Odović Jadranka, et al.
Published: (2006-01-01)

Reversed-phase thin-layer chromatography of some angiotensin converting enzyme (ACE) inhibitors and their active metabolites
by: JADRANKA ODOVIC, et al.
Published: (2006-06-01)